At the end of the day, if something as simple as appointment scheduling is enough to significantly prolong life for cancer ...

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the Stocks With Huge Catalysts on the Horizon. On June 2, UroGen Pharma Ltd.

One of the world’s largest clinical studies on lung cancer—with significant Greek participation—was recently presented at the ...

Overall, research shows that dairy can lower the risk of some cancers and increase the risk of others. This is why no ...

Researchers at Sylvester Comprehensive Cancer Center reveal how body composition analysis predicts treatment response in ...

Johnson & Johnson launches The 3rd Opinion in Asia Pacific: a new term to elevate the patient voice in the lung cancer ...

July brought major breast cancer updates, and CURE is sharing the latest, as recent developments underscore how quickly the landscape continues to evolve.

Katherine McDaniel, MD, a reproductive endocrinologist, discusses the key takeaways for oncologists treating patients of reproductive age.

Panelists discuss how real-world evidence studies from databases like Flatiron demonstrate that second-generation Bruton ...

(Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the first patient has been dosed in the pivotal Phase 3 OVATION 3 Study ...